These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 8315571)
21. Gingival crevicular fluid matrix metalloproteinase-13 levels and molecular forms in various types of periodontal diseases. Ilgenli T; Vardar-Sengul S; Gürkan A; Sorsa T; Stackelberg S; Köse T; Atilla G Oral Dis; 2006 Nov; 12(6):573-9. PubMed ID: 17054770 [TBL] [Abstract][Full Text] [Related]
22. [Proteinases as a pathogenetic factor in inflammatory processes in periodontal tissues]. Ezikian TI; Leont'ev VK; Solov'eva NI; Kosorukova NIa; Kiriukhina SA Biull Eksp Biol Med; 1991 Sep; 112(9):254-6. PubMed ID: 1660739 [TBL] [Abstract][Full Text] [Related]
23. Preliminary studies on cysteine and serine proteinase activities in inflamed human gingiva using different 7-amino-4-trifluoromethyl coumarin substrates and protease inhibitors. Cox SW; Eley BM Arch Oral Biol; 1987; 32(9):599-605. PubMed ID: 3481958 [TBL] [Abstract][Full Text] [Related]
24. Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Dickinson DP Crit Rev Oral Biol Med; 2002; 13(3):238-75. PubMed ID: 12090464 [TBL] [Abstract][Full Text] [Related]
25. Immunochemical quantitation of cysteine proteinase inhibitor cystatin C in inflamed human gingiva. Skaleric U; Babnik J; Curin V; Lah T; Turk V Arch Oral Biol; 1989; 34(4):301-5. PubMed ID: 2597024 [TBL] [Abstract][Full Text] [Related]
26. Regulation of proteolytic enzyme activities in muscles practice and hypothesis. Sohár I Acta Biol Hung; 1991; 42(1-3):183-201. PubMed ID: 1844310 [TBL] [Abstract][Full Text] [Related]
27. A biochemical study of serine proteinase activities at local gingival tissue sites in human chronic periodontitis. Eley BM; Cox SW Arch Oral Biol; 1990; 35(1):23-7. PubMed ID: 2202277 [TBL] [Abstract][Full Text] [Related]
28. [The proteinase inhibitors of mixed saliva in periodontitis]. Vavilova TP; Tolmacheva II Stomatologiia (Mosk); 1991; (2):4-6. PubMed ID: 1853378 [TBL] [Abstract][Full Text] [Related]
29. The Expression of Lysosomal Proteinases and Their Inhibitors in Breast Cancer: Possible Relationship to Prognosis of the Disease. Lah TT; Kos J; Blejec A; Frkovic-Georgio S; Golouh R; Vrhovec I; Turk V Pathol Oncol Res; 1997; 3(2):89-99. PubMed ID: 11173633 [TBL] [Abstract][Full Text] [Related]
30. Cystatins in health and disease. Henskens YM; Veerman EC; Nieuw Amerongen AV Biol Chem Hoppe Seyler; 1996 Feb; 377(2):71-86. PubMed ID: 8868064 [TBL] [Abstract][Full Text] [Related]
31. Changes in coenzyme Q-dependent enzyme activities in the inflamed gingiva of dogs. Hsieh C; Inoshita E; Hanioka T; Tamagawa H; Takagaki M; Shizukuishi S J Osaka Univ Dent Sch; 1983 Dec; 23():93-8. PubMed ID: 6587049 [No Abstract] [Full Text] [Related]
32. Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway. Lu Y; Wang H; Chen S; Yang B; Li Y; Li Y J Cancer Res Clin Oncol; 2024 May; 150(5):244. PubMed ID: 38717526 [TBL] [Abstract][Full Text] [Related]
33. Validation of serum cystatin SN detection for diagnosis and poor prognosis of esophageal squamous cell carcinoma. Pi Y; Lin S; Ren X; Wang L; Song Y; Wu Z; Lai Y Front Oncol; 2024; 14():1337707. PubMed ID: 38414741 [TBL] [Abstract][Full Text] [Related]
34. Cystatin SN (CST1) as a Novel Salivary Biomarker of Periodontitis. Romano F; Franco F; Corana M; Abbadessa G; Di Scipio F; Pergolizzi B; Castrignano C; Aimetti M; Berta GN Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762137 [TBL] [Abstract][Full Text] [Related]
35. Weighted Correlation Network Analysis of Cancer Stem Cell-Related Prognostic Biomarkers in Esophageal Squamous Cell Carcinoma. Zhao M; Jin X; Chen Z; Zhang H; Zhan C; Wang H; Wang Q Technol Cancer Res Treat; 2022; 21():15330338221117003. PubMed ID: 35899307 [No Abstract] [Full Text] [Related]
36. An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma. Zhang H; Shi Q; Yang Z; Wang K; Zhang Z; Huang Z; Cui X; Li F Front Mol Biosci; 2021; 8():598427. PubMed ID: 33869274 [TBL] [Abstract][Full Text] [Related]
37. CST1 Promoted Gastric Cancer Migration and Invasion Through Activating Wnt Pathway. Chen S; Liu Y; Zhang K; Chen L Cancer Manag Res; 2021; 13():1901-1907. PubMed ID: 33658852 [TBL] [Abstract][Full Text] [Related]
38. Upregulation of cystatin SN promotes hepatocellular carcinoma progression and predicts a poor prognosis. Cui Y; Sun D; Song R; Zhang S; Liu X; Wang Y; Meng F; Lan Y; Han J; Pan S; Liang S; Zhang B; Guo H; Liu Y; Lu Z; Liu L J Cell Physiol; 2019 Dec; 234(12):22623-22634. PubMed ID: 31106426 [TBL] [Abstract][Full Text] [Related]
39. Cystatin SN inhibits auranofin-induced cell death by autophagic induction and ROS regulation via glutathione reductase activity in colorectal cancer. Oh BM; Lee SJ; Cho HJ; Park YS; Kim JT; Yoon SR; Lee SC; Lim JS; Kim BY; Choe YK; Lee HG Cell Death Dis; 2017 Mar; 8(3):e2682. PubMed ID: 28300829 [TBL] [Abstract][Full Text] [Related]
40. Cystatin C in aging and in Alzheimer's disease. Mathews PM; Levy E Ageing Res Rev; 2016 Dec; 32():38-50. PubMed ID: 27333827 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]